» Articles » PMID: 39007989

Clinical Management Protocols for Community Pharmacist-led Management of Urinary Tract Infections: a Review of the Grey Literature and Quality Appraisal

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2024 Jul 15
PMID 39007989
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pharmacist-led management of urinary tract infections has been introduced as a service in the United Kingdom, Canada, United States of America, New Zealand, and Australia. The management of acute uncomplicated urinary tract infections by community pharmacists has gained increasing attention as a potential avenue to alleviate the burden on primary healthcare services.

Aim: The objectives of the review were to: (1) identify protocols for community pharmacist management of acute uncomplicated urinary tract infections in women aged 16-65 years; (2) outline their key components; and (3) appraise the quality of protocols.

Method: A grey literature search was undertaken for protocols intended for use by community pharmacists for the management of acute uncomplicated urinary tract infections in women aged 16-65 years, met the definition of a clinical management protocol and written in English. Their quality was appraised using the Appraisal Guidelines for Research and Evaluation version II instrument.

Results: Forty of the 274 records screened were included. Content analysis identified ten key components: common signs/symptoms, differential diagnosis, red flags/referral, choice of empirical antibiotic therapy, nonprescription medications, nonpharmacological/self-care advice, patient eligibility criteria, patient follow-up, dipstick testing recommendations, and recommendations on antimicrobial resistance. The lowest scoring domains in the quality assessment were 'Editorial Independence' and 'Rigour of Development'. Only four protocols were deemed high-quality.

Conclusion: The review demonstrates that clinical management protocols for pharmacist-led management of urinary tract infections consist of similar recommendations, despite variation in international practice. However, the findings highlight a deficiency in the quality of most clinical management protocols governing pharmacist-led urinary tract infection management.

Citing Articles

Evidence summary on management strategies for gastroesophageal reflux symptoms in patients following esophageal cancer surgery.

Zhao Y, Fu Y, Zhang W, Zhao S, Li H Asia Pac J Oncol Nurs. 2025; 12():100639.

PMID: 39811449 PMC: 11732502. DOI: 10.1016/j.apjon.2024.100639.

References
1.
Benzies K, Premji S, Hayden K, Serrett K . State-of-the-evidence reviews: advantages and challenges of including grey literature. Worldviews Evid Based Nurs. 2006; 3(2):55-61. DOI: 10.1111/j.1741-6787.2006.00051.x. View

2.
Bowers S, Black P, McCheyne L, Wilson D, Mills S, Agrawal U . Current definitions of advanced multimorbidity: a protocol for a scoping review. BMJ Open. 2023; 13(11):e076903. PMC: 10689385. DOI: 10.1136/bmjopen-2023-076903. View

3.
Little P, Moore M, Turner S, Rumsby K, Warner G, Lowes J . Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010; 340:c199. PMC: 2817051. DOI: 10.1136/bmj.c199. View

4.
Watkins K, Wood H, Schneider C, Clifford R . Effectiveness of implementation strategies for clinical guidelines to community pharmacy: a systematic review. Implement Sci. 2015; 10:151. PMC: 4627629. DOI: 10.1186/s13012-015-0337-7. View

5.
Swart A, Benrimoj S, Dineen-Griffin S . The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review. Int J Clin Pharm. 2024; 46(3):574-589. DOI: 10.1007/s11096-023-01679-6. View